Searched for
BRILINTA
MNC pharma: Time to relook at them? 8 pharma stocks, 4 with an upside potential of between 16 and 47%In the past four years, several MNC pharma companies announced the sale of a part of their businesses in India. Some of this was part of gl...03 Dec, 2024, 04.06 PM IST- Be bullish, just manage risks & desire; 5 midcap stocks for long term investorsIn a bullish market many things change and one of them is the relationship between opportunity and challenges. Given the way markets are pa...14 Jul, 2024, 03.53 PM IST
- AstraZeneca bets on licencing deals, public-private partnerships for India growthBritish-Swedish drugmaker AstraZeneca is set to launch 15 new products in India from 2023 to 2025, focusing on oncology, cardiovascular, re...09 Mar, 2024, 12.53 AM IST
- Will the wave of restructuring help? 7 MNC pharma stocks with upside potential of up to 14%In the last three years, Novartis is the third MNC pharma company which has announced sale of a part of its business in India. Some of thes...23 Feb, 2024, 03.29 PM IST
- For calibrating and diversifying risks? 6 midcap stocks from different sectors with the right financial matrixAs the Dalal street continues to be in party mode, staying bullish would appear to be the most logical thing at this point of time. Why fig...13 Jan, 2024, 02.37 PM IST
- Buy Sun Pharmaceutical Industries, target Rs 581: Nirmal Bang Institutional EquitiesBuy Sun Pharmaceutical Industries at a price target of Rs 581.06 Mar, 2019, 05.33 PM IST
- Dr Reddy's trades steady, shrugs off legal challengeDRL’s generic version was to be marketed as Ticaflo, according to those in the know.25 Jul, 2018, 11.00 AM IST
- L&T, Hero MotoCorp, Dr Reddy's & Asian Paints among top stocks to track todayHere is a list of stocks that are likely to remain in focus in today's session.25 Jul, 2018, 08.18 AM IST
- Market Movers: BRICS meet starts; IMF cautions India; truckers' stir impact & moreA lowdown on top macro triggers that may move market on Wednesday.25 Jul, 2018, 08.16 AM IST
- AstraZeneca sues DRL on patentCopies of the drug can be manufactured only after all the patents covering it expire, AstraZeneca’s counsel argued in court on Tuesday.24 Jul, 2018, 10.57 PM IST
- AstraZeneca rallies over 37% in June on Forxiga launch; more gains likelyAstraZeneca have broken out of the narrow trading range in June, driven by two positive news flows. The stock has rallied 37.41% since June...23 Jun, 2015, 04.13 PM IST
- Sun Pharma, AstraZeneca seal distribution dealThe drug majors have entered into a distribution services agreement to distribute AstraZeneca's heart disease treatment drug 'Axcer' in Ind...02 Jun, 2015, 12.32 PM IST
- AstraZeneca's heart pill safe to use in ambulance but comes with no extra benefitBlood-thinning drug Brilinta by AstraZeneca is safe to use in ambulance but giving it early in provides no extra benefit.01 Sep, 2014, 12.50 PM IST
- Pfizer, AstraZeneca shares climb up amidst deal talksThe two drugmakers declined to confirm the development, even as the news sent market punters to bet on the likely impact on its Indian subs...23 Apr, 2014, 04.00 AM IST
- AstraZeneca to close its Bangalore R&D unitThe decision to shut the R&D centre is part of an ongoing global restructuring exercise, said the company that employs over 1,200 people in...30 Jan, 2014, 01.34 PM IST
- Ten stocks in focus in Friday morning tradeHere is a list of ten stocks that are likely to be in action in morning trade today.30 Nov, 2012, 08.11 AM IST
- AstraZeneca launches heart drug 'Brilinta' in IndiaAstraZeneca Pharma India today launched its patented antiplatelet drug Brilinta, used to prevent heart attack, after receiving approval fro...18 Oct, 2012, 03.52 PM IST
Load More
